The various paths forward through ovarian cancer treatment can be confusing for women and often lead to difficult decisions for oncologists.
Doctors have two main approaches to treatment when they are working with ovarian cancer patients. As Dr. Jose Alejandro Rauh-Hain, a gynecologic oncologist on staff at the University of Texas MD Anderson Cancer Center, tells SurvivorNet, both of these methods of treatment offer patients a combination of chemotherapy and surgery. "At the end of the day, both groups get chemotherapy and surgery. It's just the sequence of how we do it."
Read MoreThis necessary combination of both treatments is related in part to the particular virulence of ovarian tumors. The cancer is particularly difficult to detect, so the average woman has a sizable tumor by the time she is diagnosed. As a result, both chemotherapy and debulking are needed to remove the majority of malignancies. According to the NIH, oncologists have had particular success with debulking in ovarian cancer patients, as compared with other types of cancer. The goal of a debulking procedure is to reduce the size of tumors as much as possible. If less than 1 cm of the tumor is left, that’s considered a successful surgery. From this size, chemotherapy can often further shrink the tumor to a point where there will be virtually no cancerous tissue left in the woman's abdomen. It’s important that ovarian cancer patients get to a skilled tertiary cancer center for surgery.
Learn more about SurvivorNet's rigorous medical review process.